ArticleClinical pharmacology and therapeutics2026

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma.

Ruben Malmberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.